Abstract
Aflatoxins are secondary metabolites of the fungi Aspergillus flavus and A. parasiticus. Among them, aflatoxin B1 (AFB1) is the most frequent type in nature and the most carcinogenic for mammals. It can contaminate many kinds of food like seeds, oil, olives, milk, dairy products, corn and meat, causing acute and chronic damages to the organism, especially in the liver, being, for this reason, considered highly hepatotoxic. AFB1 is also a mixed inhibitor of the enzyme acetylcholinesterase (AChE). This fact, together with its high toxicity and carcinogenicity, turns AFB1 into a potential chemical and biological warfare agent, as well as its metabolites. In order to investigate this, we performed inedited molecular modeling studies on the interactions of AFB1 and its metabolites inside the peripheral anionic site of human AChE (HssAChE), to verify their stability, suggest the preferential ways of inhibition, and compare their behavior to each other. Our results suggest that all metabolites can be better inhibitors of HssAChE than AFB1 and that AFBO and AFM1, the most toxic and carcinogenic metabolites of AFB1, are also the most effective HssAChE inhibitors among the AFB1 metabolites. Communicated by Ramaswamy H. Sarma.
References
Nov 23, 1984·Neuroscience Letters·G N Egbunike, F I Ikegwuonu
Jun 1, 1984·Toxicology Letters·N Ahmed, U S Singh
Nov 20, 1981·Science·R A Squire
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Mar 21, 1998·Electrophoresis·N Guex, M C Peitsch
Aug 16, 2002·Nature·Warren Pickett
Oct 31, 2002·Molecular Endocrinology·Hoi Sang UFarid Saljooque
Dec 1, 1964·British Journal of Cancer·W H BUTLER
Jan 23, 2004·Journal of Medicinal Chemistry·Maria KontoyianniGlenn S Sokol
Sep 3, 2004·Toxicology Letters·G J A Speijers, M H M Speijers
Dec 14, 2004·Toxicology·Maria Francesca CometaMaura Palmery
Apr 9, 2005·Proteins·Wim F VrankenErnest D Laue
Feb 7, 2006·Journal of Molecular Graphics & Modelling·Junmei WangDavid A Case
May 13, 2006·Journal of Computational Chemistry·Gerd B RochaJames J P Stewart
May 26, 2006·Journal of Medicinal Chemistry·René Thomsen, Mikael H Christensen
Nov 24, 2006·Bioinformatics·Wolfgang RiepingMichael Nilges
Apr 6, 2007·Analytical Chemistry·Fabiana ArduiniDanila Moscone
Dec 12, 2007·Journal of Computational Chemistry·Ross C WalkerDavid A Case
May 16, 2009·Current Medicinal Chemistry·Miroslav PohankaKamil Kuca
Jun 11, 2009·Protein and Peptide Letters·Miroslav PohankaKamil Kuca
Jun 12, 2009·Drug Metabolism Reviews·Qinghua WuKamil Kuca
Sep 18, 2009·Drug Metabolism Reviews
May 20, 2011·Protein Science : a Publication of the Protein Society·Benoît SansonMartin Weik
Jul 25, 2012·BMC Research Notes·Alan W Sousa da Silva, Wim F Vranken
Oct 6, 2012·Journal of Medicinal Chemistry·Jonah CheungJude J Height
May 23, 2014·Journal of Chemical Information and Modeling·Rashmi KumariAndrew Lynn
Jul 17, 2014·Archives of Toxicology·Vlastimil DohnalKamil Kuča
Oct 11, 2015·Talanta·K V StepurskaS V Dzyadevych
Nov 28, 2015·Journal of Biomolecular Structure & Dynamics·Joyce S F D de AlmeidaTanos C C França
Citations
Oct 11, 2019·BioFactors·Yujiang JiYogendra Singh
Nov 30, 2018·Journal of Biomolecular Structure & Dynamics·Danielle Rodrigues GarciaTanos Celmar Costa França
Feb 2, 2019·Journal of Biomolecular Structure & Dynamics·Yongfeng WanHao Zhang
Apr 9, 2020·Journal of Biomolecular Structure & Dynamics·Zhe JinChun Hu
Sep 28, 2018·Toxins·Joyce S F D de AlmeidaTanos C C França
Jan 8, 2021·Journal of Biomolecular Structure & Dynamics·Fernanda D BotelhoJoyce S F D de Almeida
Jan 9, 2021·Journal of Biomolecular Structure & Dynamics·Joyce S F D AlmeidaTanos C C Franca
Nov 21, 2021·Biotechnology Journal·Maryam MousivandMohammad Javan-Nikkhah